| Why aren't physicians prescribing more buprenorphine? AS Huhn, KE Dunn Journal of Substance Abuse Treatment 78, 1-7, 2017 | 319 | 2017 |
| A hidden aspect of the US opioid crisis: rise in first-time treatment admissions for older adults with opioid use disorder AS Huhn, EC Strain, DA Tompkins, KE Dunn Drug and alcohol dependence 193, 142-147, 2018 | 133 | 2018 |
| Sex‐Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder AS Huhn, MS Berry, KE Dunn The American journal on addictions 28 (4), 246-261, 2019 | 105 | 2019 |
| Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl NB Varshneya, AP Thakrar, JG Hobelmann, KE Dunn, AS Huhn Journal of addiction medicine 16 (4), e265-e268, 2008 | 100 | 2008 |
| Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone D Antoine, AS Huhn, EC Strain, G Turner, J Jardot, AS Hammond, ... The American Journal on Addictions 30 (1), 83-87, 2021 | 88 | 2021 |
| Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States AS Huhn, JG Hobelmann, JC Strickland, GA Oyler, CL Bergeria, ... JAMA Network Open 3 (2), e1920843-e1920843, 2020 | 84 | 2020 |
| Protracted renal clearance of fentanyl in persons with opioid use disorder AS Huhn, JG Hobelmann, GA Oyler, EC Strain Drug and alcohol dependence 214, 108147, 2020 | 81 | 2020 |
| Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugs DM Lydon-Staley, HH Cleveland, AS Huhn, MJ Cleveland, J Harris, ... Addictive behaviors 65, 275-282, 2017 | 73 | 2017 |
| Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence AS Huhn, RE Meyer, JD Harris, H Ayaz, E Deneke, DM Stankoski, ... Brain research bulletin 123, 102-109, 2016 | 69 | 2016 |
| Craving and opioid use disorder: A scoping review BA Kleykamp, M De Santis, RH Dworkin, AS Huhn, KM Kampman, ... Drug and alcohol dependence 205, 107639, 2019 | 61 | 2019 |
| Challenges for Women Entering Treatment for Opioid Use Disorder AS Huhn, KE Dunn Current Psychiatry Reports 22 (12), 1-10, 2020 | 60 | 2020 |
| Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence KE Dunn, AS Huhn, CL Bergeria, CD Gipson, EM Weerts Journal of Pharmacology and Experimental Therapeutics 371 (2), 422-452, 2019 | 58 | 2019 |
| Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence AS Huhn, J Harris, HH Cleveland, DM Lydon, D Stankoski, MJ Cleveland, ... Brain research bulletin 123, 94-101, 2016 | 58 | 2016 |
| A systematic review of laboratory evidence for the abuse potential of tramadol in humans KE Dunn, CL Bergeria, AS Huhn, EC Strain Frontiers in Psychiatry 10, 704, 2019 | 53 | 2019 |
| Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper AS Huhn, PH Finan, CE Gamaldo, AS Hammond, A Umbricht, ... Science Translational Medicine 14 (650), eabn8238, 2022 | 51 | 2022 |
| The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use AS Huhn, DA Tompkins, KE Dunn Drug and alcohol dependence 180, 279-285, 2017 | 50 | 2017 |
| Systematic review of sex-based differences in opioid-based effects AS Huhn, MS Berry, KE Dunn International Review of Psychiatry 30 (5), 107-116, 2018 | 49 | 2018 |
| Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients AS Huhn, MM Sweeney, RK Brooner, MS Kidorf, DA Tompkins, H Ayaz, ... Neuropsychopharmacology 44 (4), 826-833, 2019 | 47 | 2019 |
| Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes KE Dunn, EM Weerts, AS Huhn, JR Schroeder, DA Tompkins, GE Bigelow, ... Addiction biology 25 (1), e12680, 2020 | 44 | 2020 |
| Sleep disturbance as a therapeutic target to improve opioid use disorder treatment. AS Huhn, PH Finan Experimental and clinical psychopharmacology, 2021 | 43 | 2021 |
